Procter & Gamble Reiterates FY25 Outlook: Adj EPS $6.91-$7.05 vs $6.97 Est; Sales $85.720B-$87.401B vs $86.06B Est
Portfolio Pulse from Mohit Manghnani
Procter & Gamble has reiterated its fiscal year 2025 outlook, projecting adjusted EPS between $6.91 and $7.05, compared to the estimated $6.97. The company also forecasts sales between $85.720 billion and $87.401 billion, against an estimate of $86.06 billion.
October 18, 2024 | 10:59 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Procter & Gamble has reiterated its fiscal year 2025 outlook, with adjusted EPS and sales projections closely aligning with market estimates.
The reaffirmation of Procter & Gamble's FY25 outlook with figures closely matching market estimates suggests stability and predictability in its financial performance. This is likely to result in a neutral short-term impact on the stock price as there are no surprises or deviations from expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100